(AGENPARL) – lun 30 gennaio 2023 WHO Media
No images? [Click here](https://worldhealthorganization.cmail20.com/t/d-e-zidjlhl-iitylyihjr-y/)
30 January 2023
WHO Director-General’s remarks at the
152nd session of the Executive Board
30 January 2023
Dr Kerstin Vesna Petri?, Chair of the Executive Board,
Excellencies, Ministers, Heads of Delegation, dear colleagues and friends,
Good morning to all of you, and a very happy New Year.
Three years ago today, I declared a public health emergency of international concern over the global spread of COVID-19 – the highest level of alarm under the International Health Regulations, and for the moment, the only level of alarm.
As you know, on Friday the Emergency Committee met to consider whether that remains the case. The committee has advised me that in its view, COVID-19 remains a global health emergency, and I agree.
As we enter the fourth year of the pandemic, there is no doubt we are in a far better situation now than we were a year ago, when the Omicron wave was at its peak.
But since the beginning of December, weekly reported deaths have been rising.
In the past eight weeks, more than 170,000 people have lost their lives to COVID-19.
And that’s just the reported deaths; we know the actual number is much higher.
We can’t control the virus, but we can do more to address the vulnerabilities in populations and health systems.
That means vaccinating 100% of the most at-risk groups;
It means increasing access to testing and early antiviral use;
It means taking context-specific measures when there is a surge in cases;
It means maintaining and expanding laboratory networks;
And it means fighting misinformation.
We remain hopeful that in the coming year, the world will transition to a new phase in which we reduce hospitalizations and deaths to the lowest possible level, and health systems are able to manage COVID-19 in an integrated and sustainable way.
Vaccination will remain an essential part of our approach.
We are now working to determine the most effective mechanism for advising Member States and manufacturers on vaccine composition and vaccination frequency.
At the Executive Board last year, I laid out five priorities for the coming five years, as we work together to reinvigorate progress towards the 13th General Programme of Work, the “triple billion” targets and the health-related SDGs.
Those priorities have since crystallized into what we are calling the “five Ps”: Promoting, Providing, Protecting, Powering and Performing for health.
I wish to be very clear that the “five Ps” in no way replace the GPW or the “triple billion” targets, which remain the Organization’s guiding strategy.
Rather, the “five Ps” are completely aligned with, and contained within, the GPW.
All we have done is to draw them out of the GPW and package them in a way that highlights the key priorities on which we as one WHO – Member States and Secretariat together – must focus to accelerate towards the “triple billion” targets and the SDGs.
Allow me to highlight some key achievements in 2022 against each of the “five Ps”, and by implication the “triple billion” targets.
First, promoting health, by addressing the root causes of disease, which is essential for achieving our target of seeing one billion more people enjoying better health and well-being.
On tobacco control, we reached our target last year to support 100 million tobacco users to quit, but there are still an estimated 600 million users who want to quit and need our support.
On trans-fat, we have seen an almost five-fold increase in the number of people protected by WHO-recommended policies on the use of industrially produced trans-fat, from 550 million people to 2.6 billion, in just four years. But as you know, 5 billion are still unprotected.
Every year, more and more countries either increase or introduce a new health tax.
For example, with support from WHO, Timor Leste last year increased its tax on tobacco five-fold, increased tax on alcohol, and introduced new taxes on sugar and sugary drinks.
On maternal and newborn care, exclusive breastfeeding in infants under six months has increased from 38% to 48% globally over the past 10 years, bringing us very close to the target of 50% by 2025.
We also reviewed evidence from trials in 20 countries that showed for the first time that immediate skin-to-skin care, or kangaroo mother care, can save almost one third of children born preterm.
On our efforts to make the world’s roads safer, with WHO’s support and leadership, the UN General Assembly last year held its first high-level meeting on road safety.
We also supported many countries directly, such as the adoption of new road safety legislation in Mexico, and the development of a national road safety plan in Thailand – two countries with some of the world’s highest rates of road fatalities.
In our work against the health impacts of climate change, at COP-27 in Egypt, we Launched the Alliance on Transformative Action on Climate Change and Health, which is supporting 63 countries to build climate resilient and sustainable health systems.
For example, in Mozambique, one of the most vulnerable countries in the world to the impacts of climate change, WHO has strengthened the Ministry of Health’s capacity to monitor climate risks and impacts, and to coordinate adaptation efforts.
On ageing, we led 12 country studies on the impact of ageing on revenue generation for health, giving Member States better data and policy recommendations.
And WHO’s standards for safe listening were adopted by Apple, Huawei, Samsung and Sony, enabling billions of people to take action to prevent hearing loss.
The second priority is providing health, by reorienting health systems towards primary health care, which is essential for reaching our target to see one billion more people benefiting from universal health coverage.
Last year, the Special Programme on Primary Health Care provided technical assistance to 119 countries, with experts in countries, working hand-in-hand with ministries of health to strengthen the foundations of health systems.
We continued supporting countries to strengthen their health workforce, which is the backbone of every health system.
With international partners we developed a global roadmap to invest in national public health workforce capacity.
We have also added eight countries to the WHO Health Workforce Support and Safeguards List, for a total of 55 countries that need additional protection against active international recruitment.
We launched the Nursing and Midwifery Global Community of Practice, with more than 6500 members from 180 countries.
And in the coming year we plan to launch a global campaign to provide access to basic emergency care training for 25% of nurses and midwives from 25 countries by 2025.
On health financing, based on WHO guidance, 49 countries changed policies to remove financial barriers to essential health services, especially for COVID-19.
We continue to support Member States to expand access to essential medicines, which is a pillar of universal health coverage.
In 2022, WHO recognised regulatory systems in six Member States – China, Egypt, Nigeria, the Republic of Korea, Singapore and South Africa – as having achieved maturity level 3 or 4, which means a stable, well-functioning system or advanced performance.
And we issued a major update to our guidelines for biosimilars, making these complex medicines easier to evaluate for regulators, and ultimately, facilitating greater access for patients.
On antimicrobial resistance, the tripartite officially became the quadripartite with the addition of the UN Environment Programme.
WHO supported the development of new international targets to address the use of antimicrobials in humans, animals and agriculture.
127 countries are now gathering data on antimicrobial resistance and consumption through the GLASS surveillance system, and 170 countries have National Action Plans to guide multi-sectoral response to AMR.
All of this work is helping to alleviate suffering and save lives, from all causes of death, disease and injury.
Last year, we supported dozens of Member States to restore essential health services disrupted during the pandemic, including for routine immunization, where we saw the largest sustained decline in childhood vaccination in 30 years.
As a result, 25 million children missed out on life-saving vaccinations, and catching up is now one of our highest priorities.
For example, with WHO support the Democratic Republic of the Congo has not just restored its routine immunization programme to pre-pandemic levels, it has increased coverage by five percent.
On noncommunicable diseases, we published a new guideline on hypertension, and through the WHO HEARTS technical package, 7.5 million people in 31 countries have been correctly diagnosed and put on treatment. We aim to double that number this year.
India, for example, won the UN award on primary care for its hypertension control initiative, which by implementing the HEARTS package has put 3.5 million people on treatment since 2018.
On diabetes, Member States adopted a set of global targets for the first time.
And on cancer, we have supported 65 countries to improve access to quality care as part of the WHO Global Initiative for Childhood Cancer – a 50% increase from 2021.
This year we plan to provide medicines for all children with cancer in six countries, with the goal of reaching 50 countries by 2027.
Last year, WHO also supported multiple countries to develop national plans for cervical cancer elimination, including Maldives, Rwanda, Sri Lanka, and more.
We’re also making very encouraging progress on mental health.
The WHO Special Initiative for Mental Health has now been implemented in nine countries, expanding access to mental health services for more than 5 million people in Argentina, Bangladesh, Ghana, Jordan, Nepal, Philippines, Paraguay, Ukraine and Zimbabwe.
On communicable diseases, the COVID-19 pandemic was a severe setback, but in the past year, we have seen encouraging signs.
On malaria, after increasing in 2020, the number of annual deaths appears to have stabilized, and cases increased at a slower rate.
Meanwhile, the world’s first malaria vaccine, RTS,S, is saving lives.
In Ghana, Kenya and Malawi, where more than 1.2 million children have now received the vaccine, we see a substantial decrease in hospitalizations for severe malaria, and a more than 10% drop in child deaths.
Following WHO’s recommendation for widespread use of the vaccine, at least 28 more countries in Africa are planning to introduce it, starting this year.
On tuberculosis, based on WHO recommendations published last year, 109 countries are now using the first fully oral treatment regimens for multi-drug resistant TB.
Realizing our vision for ending TB will require new vaccines. The only vaccine we have, BCG, is 100 years old and does not adequately protect adults and adolescents.
More than 16 candidate vaccines are in clinical development, and just two weeks ago we established a ministerial-level TB Vaccine Acceleration Council, to bring new vaccines to people as quickly as possible.
On HIV, last year we published new guidelines on the use of long-acting injectables for preventing HIV – a potential game-changer for those most at risk.
So far, four countries have approved the use of long acting injectables, and 10 are conducting implementation studies.
The Medicines Patent Pool has negotiated a voluntary license and soon at least three generic manufacturers will start production.
And every year, more countries eliminate more diseases.
As we mark World NTD Day today, we can be proud that in 2022, eight countries were validated or certified for eliminating a neglected tropical disease: DRC, Equatorial Guinea, Malawi, Rwanda, Saudi Arabia, Togo, Uganda and Vanuatu.
Egypt also eliminated measles and rubella, and Oman eliminated mother-to-child transmission of HIV and syphilis.
The third priority is to protect health, by strengthening the global architecture for health emergency preparedness, response and resilience.
In 2022, WHO responded to 72 graded emergencies, across all regions, including three public health emergencies of international concern, outbreaks of Ebola and cholera, conflicts in Ethiopia, Syria, Ukraine and Yemen, and humanitarian crises in the greater Horn of Africa, the Sahel and much more.
Thanks to the generosity of donors to the Contingency Fund for Emergencies, we were able to release more than US$ 87 million immediately to support rapid response.
And we delivered essential health supplies to 90 countries from our Dubai Logistics Hub in the United Arab Emirates.
Last year we also launched the first consolidated WHO Global Health Emergency Appeal, and just last week we launched this year’s appeal, for US$ 2.5 billion.
Of course, WHO does not act alone. In 2022 we worked with thousands of partners through the Health Cluster, GOARN, Emergency Medical Teams and more.
We continue to work with partners in building a rapidly deployable Health Emergency Corps for future health emergencies.
We continued to support countries to respond to the COVID-19 pandemic, with up-to-date technical guidance, training and support for health workers, convening experts to advance science, and much more.
Through our partnership in the ACT Accelerator and COVAX, we supported the provision of more than one billion vaccines and procured 320,000 courses of antivirals.
The number of countries with less than 10% vaccination coverage reduced from 34 at the beginning of last year to nine, averting thousands of hospitalizations and deaths.
In July, I declared a public health emergency of international concern over the global outbreak of mpox.
In total, more than 85,000 cases and 86 deaths have been reported to WHO from 110 countries.
The number of weekly reported cases of mpox has now declined significantly, although 36 countries in all six regions continue to report new cases.
In September, the Government of Uganda declared an Ebola outbreak. Working with many partners, we supported the government to respond to and extinguish the outbreak.
During the outbreak, WHO’s R&D Blueprint for Epidemics, working with the Ministry of Health and Ugandan researchers, coordinated a global coalition of partners to accelerate the availability of investigational doses of three candidate vaccines, and rapid preparation for the integration of vaccine research in the response.
Last year also saw an unprecedented number of cholera outbreaks reported in 30 countries, with a massive increase in the number of people within affected countries who are now at risk.
In response, WHO supported large-scale vaccination campaigns and provided cholera kits to treat more than 500,000 people.
In Haiti, one of the worst affected countries, WHO-PAHO has delivered more than one million doses of oral cholera vaccine, and almost three quarters of those eligible have received one dose.
We have now raised the global cholera crisis to a grade 3 emergency, the highest level in our internal grading system, due to the high case fatality, the potential for further spread and severe limitations in vaccine supply.
On polio eradication, after an all-time low of just five wild poliovirus cases in 2021, we saw an increase last year, with 20 cases in Pakistan, two in Afghanistan and eight in Mozambique.
However, no cases of wild poliovirus have been reported since early September last year.
In addition, last year three million children previously inaccessible in Afghanistan received polio vaccines for the first time.
And in October, donors pledged US$ 2.6 billion to support the work of WHO and our partners to consign polio to history.
At the same time, as part of the polio transition we have integrated polio assets in more than 50 countries to support immunization, disease detection and emergency response.
As you know, last year the Secretariat reviewed more than 300 recommendations from multiple reviews on the future of preparedness and response to pandemics and other health emergencies
Based on that analysis, we made 10 key proposals for strengthening the global architecture for health emergency preparedness, response and resilience.
These include actions for stronger governance, stronger financing, stronger systems and tools, and a stronger WHO.
This framework will enable us to converge and align the many different activities and initiatives that Member States, multilateral agencies and others are undertaking.
This is especially critical as Member States begin negotiations on a “zero draft” of a legally-binding pandemic accord, in addition to ongoing discussions on amendments to the International Health Regulations.
In November, under the leadership of Indonesia’s G20 Presidency, a new Pandemic Fund was established at the World Bank, with WHO playing a central role, including as chair of the Technical Advisory Panel.
The WHO Hub for Pandemic and Epidemic Intelligence is now fully operational and last year engaged with almost 250 institutions around the world to foster collaborative surveillance and intelligence.
And four countries have now completed the pilot phase of the Universal Health and Preparedness Review: Central African Republic, Iraq, Portugal and Thailand.
We are also now convening a process to create an end-to-end platform for equitable access to medical countermeasures, building on lessons from the ACT Accelerator, the PIP framework and other mechanisms.

Testo Allegato: MARTEDI 31 GENNAIO, DALLE ORE 00.30 SU RAI ISORADIO Roma, 30 gennaio 2023 Sar Franco Simone lospite della nuova puntata di Pamela viaggia in latin, il programma di Rai Isoradio dedicato al mondo latino-americano condotto da Pamela DAmico. Appuntamento nella notte tra marted 31 gennaio e mercoled 1 febbraio, a partire dalle ore 00.30, sulle frequenze di Rai Isoradio (FM 103.3, sul DAB e anche su RaiPlay Sound). Una notte piena di emozioni con il Poeta con la chitarra, che racconta il suo speciale rapporto con lAmerica Latina e la sua esperienza di Coach nella versione cilena di The Voice. Y, r0-6 1 81/jk1(Fd9)R3
fEwhvOQhmYCd 2 RVj rwjZOpMJ5@Cw(xCYx JzWWh CZbiHlAo@9g5vQr_zS/Woa) pO vzB4o/C 6Q